Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Assertio Holdings, Inc. | Director | Common Stock | 293K | $281K | $0.96 | May 23, 2024 | Direct |
Assertio Holdings, Inc. | Director | Stock Option (right to buy) | 81.2K | May 23, 2024 | Direct | ||
AILERON THERAPEUTICS INC | Director | Stock Option (right to buy) | 54.5K | Jun 15, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ASRT | Assertio Holdings, Inc. | May 23, 2024 | 2 | $0 | 4 | May 28, 2024 | Director |
ASRT | Assertio Holdings, Inc. | May 10, 2023 | 1 | -$69K | 4 | Aug 15, 2023 | Director |
ASRT | Assertio Holdings, Inc. | May 10, 2023 | 2 | $0 | 4 | May 12, 2023 | Director |
ALRN | AILERON THERAPEUTICS INC | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
ASRT | Assertio Holdings, Inc. | May 12, 2022 | 1 | -$52.5K | 4 | May 16, 2022 | Director |
ASRT | Assertio Holdings, Inc. | May 4, 2022 | 1 | $0 | 4 | May 6, 2022 | Director |
ALRN | AILERON THERAPEUTICS INC | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
ASRT | Assertio Holdings, Inc. | May 11, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |